Why Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) Is Worth A Spot On Your Watchlist
Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 0.31. At the close